Butobarbital

Butobarbital
Clinical data
Trade names	Soneryl
AHFS/Drugs.com	International Drug Names
Routes of; administration	By mouth
ATC code	N05CA03 (WHO) ;
Legal status
Legal status	AU: S8 (Controlled drug); CA: Schedule IV; DE: Anlage II (Authorized trade only, not prescriptible);
Pharmacokinetic data
Metabolism	Liver
Excretion	Kidney
Identifiers
	IUPAC name 5-Butyl-5-ethyl-1,3-diazinane-2,4,6-trione;
CAS Number	77-28-1 ;
PubChem CID	6473;
DrugBank	DB01353 ;
ChemSpider	6229 ;
UNII	OHZ8QAW6YC;
KEGG	D02618 ;
ChEMBL	ChEMBL404422 ;
CompTox Dashboard (EPA)	DTXSID70227808 ;
ECHA InfoCard	100.000.928
Chemical and physical data
Formula	C10H16N2O3
Molar mass	212.249 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C1NC(=O)NC(=O)C1(CCCC)CC;
	InChI InChI=1S/C10H16N2O3/c1-3-5-6-10(4-2)7(13)11-9(15)12-8(10)14/h3-6H2,1-2H3,(H2,11,12,13,14,15) ; Key:STDBAQMTJLUMFW-UHFFFAOYSA-N ;
	(verify)

Butobarbital, also called butobarbitone or butethal, Soneryl, and Neonal,^[1] is a hypnotic drug which is a barbiturate derivative.^[2] It was developed by Poulenc Brothers (now part of Sanofi) in 1921.^[3]

Quick Facts Clinical data, Trade names ...

[1]

[2]

[3]

Butobarbital

References

Wikiwand - on